Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Evidence from in vitro differentiating cells that adrenoceptor agonists can increase uncoupling protein mRNA level in adipocytes of adult humans: an RT-PCR study.

Champigny O., Ricquier D.

Laboratory Study on Systemic / IV, published in J Lipid Res (1996) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
J Lipid Res (1996)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
8895056

Abstract (original English)

In vivo data have suggested that adrenergic signals can reactivate dormant brown adipocytes in adult humans. We report here a system based on primary cultures of perirenal adipocytes from human adults and reverse transcription-PCR of uncoupling protein mRNA. Norepinephrine and compounds classified as beta 3-adrenoceptor agonists in rodents increased uncoupling protein mRNA level in human adipocytes (presumably brown adipocytes). Although we did not demonstrate that the observed effect was mediated by beta 3-adrenoceptors, it is proposed that this system could be used to appreciate the ability of beta-adrenoceptor agonists to activate UCP gene transcription and help to select beta 3-adrenoceptor agonists and antagonists prior to in vivo trials; indeed, the difficulty in developing such drugs that are effective in humans may result from the fact that the screening of molecules has historically been made in rodents.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesAdipose Tissue, BrownAdrenergic beta-AgonistsAdultCarrier ProteinsCell DifferentiationCells, CulturedHumansHyperaldosteronismIon Channels

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research